Larimar Therapeutics LRMR
NASDAQ LRMR
$2.26 -0.16 (-6.61%)
As of: Oct 22, 2026 · 3:46 PM EDT

Larimar Therapeutics (LRMR) Preferred Shares (2026)

Updated

Larimar Therapeutics' Preferred Shares came in at $1,000 for Q2 2026.

Analysis

Larimar Therapeutics (LRMR) Preferred Shares (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,167.71 Bn 1,136.29 Bn 19.71 Bn -
2 Johnson & Johnson 647.75 Bn 567.61 Bn 17.30 Bn -
3 AbbVie 503.60 Bn 476.71 Bn 12.70 Bn -
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn -
5 Novartis Ag 303.19 Bn 267.18 Bn 11.24 Bn -
6 Astrazeneca 268.04 Bn 241.73 Bn 12.86 Bn -
7 Amgen 242.69 Bn 198.09 Bn 7.24 Bn -
8 Gilead Sciences 194.89 Bn 169.09 Bn 6.22 Bn -
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn -
10 Larimar Therapeutics 235.81 Mn -371.26 Mn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
API Access

Larimar Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=LRMR&period=max&api_key=YOUR_API_KEY